Maria C Tartaglia
Overview
Explore the profile of Maria C Tartaglia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
997
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pottier C, Kucukali F, Baker M, Batzler A, Jenkins G, van Blitterswijk M, et al.
medRxiv
. 2024 Jul;
PMID: 38978643
Frontotemporal lobar degeneration with neuronal inclusions of the TAR DNA-binding protein 43 (FTLD-TDP) is a fatal neurodegenerative disorder with only a limited number of risk loci identified. We report our...
2.
Khoury M, Churchill N, Di Battista A, Graham S, Symons S, Troyer A, et al.
J Neurol
. 2024 May;
271(7):4540-4550.
PMID: 38717612
Objectives: To investigate whether a history of traumatic brain injury (TBI) is associated with greater long-term grey-matter loss in patients with mild cognitive impairment (MCI). Methods: 85 patients with MCI...
3.
Garcia-Cordero I, Vasilevskaya A, Taghdiri F, Khodadadi M, Mikulis D, Tarazi A, et al.
J Neurol
. 2024 Apr;
271(7):4180-4190.
PMID: 38589629
Multimodal biomarkers may identify former contact sports athletes with repeated concussions and at risk for dementia. Our study aims to investigate whether biomarker evidence of neurodegeneration in former professional athletes...
4.
Rashidi-Ranjbar N, Churchill N, Black S, Kumar S, Tartaglia M, Freedman M, et al.
Int J Geriatr Psychiatry
. 2024 Mar;
39(3):e6074.
PMID: 38491809
Objectives: Neuropsychiatric symptoms (NPS) increase risk of developing dementia and are linked to various neurodegenerative conditions, including mild cognitive impairment (MCI due to Alzheimer's disease [AD]), cerebrovascular disease (CVD), and...
5.
Dilliott A, Berberian S, Sunderland K, Binns M, Zimmer J, Ozzoude M, et al.
Alzheimers Dement
. 2023 Jun;
19(12):5583-5595.
PMID: 37272523
Introduction: Cerebral small vessel disease (SVD) is common in patients with cognitive impairment and neurodegenerative diseases such as Alzheimer's and Parkinson's. This study investigated the burden of magnetic resonance imaging...
6.
Toller G, Cobigo Y, Callahan P, Appleby B, Brushaber D, Domoto-Reilly K, et al.
Alzheimers Dement
. 2023 Jan;
19(7):2842-2852.
PMID: 36591730
Introduction: Empathy relies on fronto-cingular and temporal networks that are selectively vulnerable in behavioral variant frontotemporal dementia (bvFTD). This study modeled when in the disease process empathy changes begin, and...
7.
Dilliott A, Zhang K, Wang J, Abrahao A, Binns M, Black S, et al.
Mol Genet Genomic Med
. 2022 Jun;
10(8):e1986.
PMID: 35666053
Background: Although genetic factors are known to contribute to neurodegenerative disease susceptibility, there remains a large amount of heritability unaccounted for across the diagnoses. Copy number variants (CNVs) contribute to...
8.
Sihag S, Naze S, Taghdiri F, Gumus M, Tator C, Green R, et al.
Commun Med (Lond)
. 2022 May;
2:8.
PMID: 35603281
Background: Neuro-axonal brain damage releases neurofilament light chain (NfL) proteins, which enter the blood. Serum NfL has recently emerged as a promising biomarker for grading axonal damage, monitoring treatment responses,...
9.
Ramirez J, Berberian S, Breen D, Gao F, Ozzoude M, Adamo S, et al.
Mov Disord
. 2022 Apr;
37(6):1304-1309.
PMID: 35403259
Background: Although previously thought to be asymptomatic, recent studies have suggested that magnetic resonance imaging-visible perivascular spaces (PVS) in the basal ganglia (BG-PVS) of patients with Parkinson's disease (PD) may...
10.
Wilke C, Reich S, Van Swieten J, Borroni B, Sanchez-Valle R, Moreno F, et al.
Ann Neurol
. 2021 Nov;
91(1):33-47.
PMID: 34743360
Objective: Although the presymptomatic stages of frontotemporal dementia (FTD) provide a unique chance to delay or even prevent neurodegeneration by early intervention, they remain poorly defined. Leveraging a large multicenter...